Assessing the 'added value' of European policy on new psychoactive substances. (2017)
Attributed to:
New Psychoactive Substances and Human Enhancement Drugs: new policy and practitioner landscapes
funded by
ESRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1016/j.drugpo.2016.11.002
PubMed Identifier: 27956185
Publication URI: http://europepmc.org/abstract/MED/27956185
Type: Journal Article/Review
Volume: 40
Parent Publication: The International journal on drug policy
ISSN: 0955-3959